Rosalba Minelli Selected Research

Rosalba Minelli Research Topics

Disease

19	Neoplasms (Cancer) 07/2021 - 06/2010
4	Neoplasm Metastasis (Metastasis) 11/2019 - 10/2010
4	Lung Neoplasms (Lung Cancer) 11/2019 - 03/2015
4	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 01/2011
3	Colonic Neoplasms (Colon Cancer) 01/2012 - 06/2010
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2019 - 03/2015
2	Carcinogenesis 01/2016 - 03/2015
2	Melanoma (Melanoma, Malignant) 12/2015 - 12/2013
1	Disease Progression 11/2019
1	Adenocarcinoma 11/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2012
1	Carcinoma (Carcinomatosis) 09/2010

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2021 - 10/2010
5	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 12/2015 - 09/2010
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 03/2015
3	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2019
3	CyclodextrinsIBA 01/2016 - 11/2012
3	LigandsIBA 05/2014 - 06/2010
2	Zinc Finger E-box-Binding Homeobox 1IBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2019
2	Histone Deacetylase InhibitorsIBA 01/2019 - 01/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 10/2011
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2016 - 11/2012
2	CamptothecinIBA 01/2016 - 11/2012
2	AldehydesIBA 03/2015 - 12/2013
2	Rosiglitazone (Avandia)FDA Link 01/2012 - 06/2010
2	1,3- benzothiazol- 2- yl(2- ((2- (3- pyridinyl)ethyl)amino)- 4- pyrimidinyl)acetonitrileIBA 01/2012 - 01/2012
2	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2010 - 06/2010
1	pevonedistatIBA 07/2021
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 07/2021
1	Cyclin-Dependent Kinase 4IBA 01/2021
1	Cadherins (E-Cadherin)IBA 11/2019
1	Transcription Factors (Transcription Factor)IBA 11/2019
1	Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA 11/2019
1	NucleotidesIBA 11/2019
1	pyrimidineIBA 11/2019
1	Decitabine FDA Link 11/2019
1	Immune Checkpoint InhibitorsIBA 04/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	Interleukin-17 ReceptorsIBA 01/2019
1	mocetinostatIBA 01/2019
1	AlkaloidsIBA 01/2016
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2016
1	NanocapsulesIBA 12/2015
1	immune RNA (I-RNA)IBA 10/2015
1	Inosine FDA Link 10/2015
1	Adenosine (Adenocard)FDA LinkGeneric 10/2015
1	Biomarkers (Surrogate Marker)IBA 10/2015
1	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 03/2015
1	CollagenIBA 03/2015
1	Lysine (L-Lysine)FDA Link 03/2015
1	HydroxylysineIBA 03/2015
1	ChitosanIBA 01/2014
1	Fluorouracil (Carac)FDA LinkGeneric 01/2014
1	Topoisomerase I InhibitorsIBA 11/2012
1	AndrogensIBA 11/2012
1	ciprofibrateIBA 01/2012
1	Fibric Acids (Fibrates)IBA 01/2012
1	Clofibrate FDA Link 01/2012
1	PanobinostatIBA 01/2011
1	Antineoplastic Agents (Antineoplastics)IBA 01/2011
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2010
1	PPAR gammaIBA 06/2010
1	Peroxisome ProliferatorsIBA 06/2010

Therapy/Procedure

5	Therapeutics 07/2021 - 10/2011
1	Precision Medicine 01/2016
1	Topical Administration 12/2015
1	Nanospheres 01/2014